Disclosure of interest: Name of author: nothing to disclose Poster Session I - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P254 - ESOC25-701 PILS-STROKE: DEVELOPMENT AND VALIDATION OF A QUESTIONNAIRE FOR MEASURING POST-STROKE PARTICIPATION Edouard Ducoffre 1,2 , Camille Van Hentenryck 1 , Merlin Somville 2 , Zlie Rosselli 2 , Geoffroy Saussez 1 , Yannick Bleyenheuft 2 , Carlyne Arnould 1 1 Health and medical technologies department, CeREF-Sant - Haute Ecole Louvain en Hainaut, Montignies-sur-Sambre, Belgium, 2 Institute of Neuroscience, Universit Catholique de Louvain (UCLouvain), Brussels, Belgium Background and Aims: Participation is an ultimate goal of rehabilitation, given its impact on patients quality of life
, -
90 Here, L5L6 IVDs were punctured multiple times to cause disc degeneration, injected with the retrograde neurotracer Fluorogold and different antibodies
and we will divide the geometric mean cost of each APC by the geometric mean cost for APC 5012 to derive the unscaled relative payment weight for each APC
GLP-1 vs GIP: Understanding Dual Agonist Medications If youve researched weight loss medications, youve probably seen references to GLP-1 agonists like semaglutide and dual GLP-1/GIP agonists like tirzepatide
